Catalyst Pharmaceuticals (CPRX) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.04% |
| Dec 31, 2025 | 51.48% |
| Sep 30, 2025 | 48.50% |
| Jun 30, 2025 | 46.98% |
| Mar 31, 2025 | 44.46% |
| Dec 31, 2024 | 45.11% |
| Sep 30, 2024 | 57.79% |
| Jun 30, 2024 | 52.74% |
| Mar 31, 2024 | 56.28% |
| Dec 31, 2023 | 37.24% |
| Sep 30, 2023 | 42.61% |
| Jun 30, 2023 | 45.09% |
| Mar 31, 2023 | 47.61% |
| Dec 31, 2022 | 34.65% |
| Sep 30, 2022 | 33.83% |
| Jun 30, 2022 | 33.25% |
| Mar 31, 2022 | 31.95% |
| Dec 31, 2021 | 31.47% |
| Sep 30, 2021 | 30.73% |
| Jun 30, 2021 | 28.73% |
| Mar 31, 2021 | 39.55% |
| Dec 31, 2020 | -7.46% |
| Sep 30, 2020 | -5.48% |
| Jun 30, 2020 | 21.49% |
| Mar 31, 2020 | 22.59% |
| Dec 31, 2019 | 24.14% |
| Sep 30, 2019 | 14.63% |
| Jun 30, 2019 | 17.68% |
| Mar 31, 2019 | 21.66% |
| Dec 31, 2018 | 43.29% |
| Sep 30, 2018 | 34.12% |
| Jun 30, 2018 | 29.17% |
| Mar 31, 2018 | 26.00% |
| Dec 31, 2017 | 28.95% |
| Sep 30, 2017 | 80.14% |
| Jun 30, 2017 | 74.33% |
| Mar 31, 2017 | 74.32% |
| Dec 31, 2016 | 82.13% |
| Sep 30, 2016 | 68.60% |
| Jun 30, 2016 | 58.64% |
| Dec 31, 2015 | 33.26% |